CORONA.NS

CORONA REMEDIES LIMITED

NSEHealthcare

₹2,040.00

▲ +1.54%+₹31.00 today

₹0.00₹0.00

Ask Warren

Open

₹0.00

Prev close

₹2,009.00

Day range

₹0 – ₹0

52W range

₹1,336.6 – ₹2,100.7

Volume

47.4K

Avg vol (20D)

64.8K

Mkt cap

₹12,463.81Cr

P/E TTM

67.2×

Trade CORONA REMEDIES LIMITED with Artha

Company Metrics

Revenue (ttm)₹1403.18 Cr

Net Income (ttm)₹0.00

Shares Out0.00

EPS (ttm)

Forward PE

Dividend

Ex-Dividend DateInvalid Date

Trading Metrics

Beta0.00

About CORONA.NS

CORONA Remedies Limited, a pharmaceutical formulation company, develops, manufactures, and markets pharmaceutical products. It provides products in women's healthcare, cardio-diabeto, pain management, urology, thyroid management, respiratory, nutraceuticals, gastroenterology, and other therapeutic areas. The company was incorporated in 2004 and is based in Ahmedabad, India.

IndustryDrug Manufacturers - General

SectorHealthcare

Employees5.15 K

Stock ExchangeNSE

Ticker SymbolCORONA.NS

Websitehttps://www.coronaremedies.com

CORONA.NS · NSE

Financial Performance

In 2026, CORONA REMEDIES LIMITED's revenue was ₹1403.18 Cr, an increase of +20.20% compared to the previous year. Earnings were ₹0.00, an increase of +43.60%.

Revenue (2026)

₹1403.18 Cr

↗+20.20% YoY

Earnings (2026)

₹0.00

↗+43.60% YoY

Year-over-Year Growth

Revenue

+20.20%

Earnings

+43.60%

News

Save watchlists across devicesSet price alerts that buzz your phoneConnect Zerodha for one-tap trades

Create free account